Geneva, June 20 -- International Clinical Trials Registry received information related to the study (ISRCTN12170245) titled 'Consumption of ancient grain flours as a new therapeutic option for irritable bowel syndrome' on June 13.
Study Type: Interventional
Study Design:
Randomized open-label clinical trial (Treatment)
Primary Sponsor: Magna Graecia University
Condition:
Irritable bowel syndrome
Digestive System
Intervention:
Participants will be enrolled after providing written informed consent and will be randomly assigned (by computer-generated random numbers) in a 1:1 ratio to one of two treatment groups:
Group 1: Patients following a low-FODMAP diet including the functional pasta (80 g, 4 times per week).
Group 2: Patient...